Literature DB >> 23351819

Marijuana use and long-term mortality among survivors of acute myocardial infarction.

Lauren Frost1, Elizabeth Mostofsky, Joshua I Rosenbloom, Kenneth J Mukamal, Murray A Mittleman.   

Abstract

BACKGROUND: Smoking marijuana has been reported to increase risk of myocardial infarction (MI) immediately after use, but less is known about the long-term impact of marijuana use among patients with established coronary disease.
METHODS: The Determinants of MI Onset Study is a multicenter inception cohort study of myocardial infarction (MI) patients enrolled in 1989 to 1996 and followed up for mortality using the National Death Index. In an initial analysis of 1,935 MI survivors followed up for a median of 3.8 years, we found an increased mortality rate among marijuana users. The current article includes 3,886 Determinants of MI Onset Study patients followed up for up to 18 years. We used Cox proportional hazards models to calculate the hazard ratio and 95% CI for the association between marijuana use and mortality and a propensity score matched analysis to further control confounding.
RESULTS: Over up to 18 years of follow-up, 519 patients died, including 22 of the 109 reporting marijuana use in the year before their MI. There was no statistically significant association between marijuana use and mortality. Compared with nonusers, the mortality rate was 29% higher (95% CI 0.81-2.05, P = .28) among those reporting any marijuana use.
CONCLUSIONS: Habitual marijuana use among patients presenting with acute MI was associated with an apparent increased mortality rate over the following 18 years that did not reach nominal statistical significance. Larger studies with repeated measures of marijuana use are needed to definitively establish whether there are adverse cardiovascular consequences of smoking marijuana among patients with established coronary heart disease.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23351819      PMCID: PMC3558923          DOI: 10.1016/j.ahj.2012.11.007

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  29 in total

1.  Toxic effects of marijuana on the cardiovascular system.

Authors:  Balaji Pratap; Aleksandr Korniyenko
Journal:  Cardiovasc Toxicol       Date:  2012-06       Impact factor: 3.231

2.  Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: a nationwide follow-up study of Danish substance users in treatment.

Authors:  Mikkel Arendt; Povl Munk-Jørgensen; Leo Sher; Signe O W Jensen
Journal:  Drug Alcohol Depend       Date:  2010-10-25       Impact factor: 4.492

3.  Mortality among substance-using mothers in California: a 10-year prospective study.

Authors:  Yih-Ing Hser; Jamie Kagihara; David Huang; Elizabeth Evans; Nena Messina
Journal:  Addiction       Date:  2011-10-26       Impact factor: 6.526

4.  Myocardial infarction associated with use of the synthetic cannabinoid K2.

Authors:  Arshid Mir; Adebisi Obafemi; Amy Young; Colin Kane
Journal:  Pediatrics       Date:  2011-11-07       Impact factor: 7.124

5.  Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.

Authors:  Mohanraj Rajesh; Sándor Bátkai; Malek Kechrid; Partha Mukhopadhyay; Wen-Shin Lee; Béla Horváth; Eileen Holovac; Resat Cinar; Lucas Liaudet; Ken Mackie; György Haskó; Pál Pacher
Journal:  Diabetes       Date:  2012-02-07       Impact factor: 9.461

6.  Self-reported drug use and mortality among a nationwide sample of Swedish conscripts - a 35-year follow-up.

Authors:  Ingrid Davstad; Peter Allebeck; Anders Leifman; Marlene Stenbacka; Anders Romelsjö
Journal:  Drug Alcohol Depend       Date:  2011-06-12       Impact factor: 4.492

7.  Mortality risk in a cohort of subjects reported by authorities for cannabis possession for personal use. Results of a longitudinal study.

Authors:  Raimondo Maria Pavarin; Domenico Berardi
Journal:  Epidemiol Prev       Date:  2011 Mar-Apr       Impact factor: 1.901

8.  Mortality associated with illegal drug use among adults in the United States.

Authors:  Pradip K Muhuri; Joseph C Gfroerer
Journal:  Am J Drug Alcohol Abuse       Date:  2011-05       Impact factor: 3.829

Review 9.  Is lipid signaling through cannabinoid 2 receptors part of a protective system?

Authors:  P Pacher; R Mechoulam
Journal:  Prog Lipid Res       Date:  2011-02-02       Impact factor: 16.195

10.  Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity.

Authors:  Alessandra Quercioli; Zoltan Pataky; Gabriella Vincenti; Vincent Makoundou; Vincenzo Di Marzo; Fabrizio Montecucco; Sebastian Carballo; Aurélien Thomas; Christian Staub; Sabine Steffens; Yann Seimbille; Alain Golay; Osman Ratib; Elisabetta Harsch; François Mach; Thomas H Schindler
Journal:  Eur Heart J       Date:  2011-02-08       Impact factor: 29.983

View more
  28 in total

Review 1.  Medical consequences of marijuana use: a review of current literature.

Authors:  Adam J Gordon; James W Conley; Joanne M Gordon
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

2.  Cannabis and Young Users-A Brief Intervention to Reduce Their Consumption (CANABIC): A Cluster Randomized Controlled Trial in Primary Care.

Authors:  Catherine Laporte; Hélène Vaillant-Roussel; Bruno Pereira; Olivier Blanc; Bénédicte Eschalier; Shérazade Kinouani; Georges Brousse; Pierre-Michel Llorca; Philippe Vorilhon
Journal:  Ann Fam Med       Date:  2017-03       Impact factor: 5.166

Review 3.  Role of cannabis in cardiovascular disorders.

Authors:  Hemant Goyal; Hamza H Awad; Jalal K Ghali
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

4.  Assessing the public health impacts of legalizing recreational cannabis use: the US experience.

Authors:  Wayne Hall; Michael Lynskey
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

5.  Cocaine and Marijuana Use Among Young Adults With Myocardial Infarction.

Authors:  Ersilia M DeFilippis; Avinainder Singh; Sanjay Divakaran; Ankur Gupta; Bradley L Collins; David Biery; Arman Qamar; Amber Fatima; Mattheus Ramsis; Daniel Pipilas; Roxanna Rajabi; Monica Eng; Jon Hainer; Josh Klein; James L Januzzi; Khurram Nasir; Marcelo F Di Carli; Deepak L Bhatt; Ron Blankstein
Journal:  J Am Coll Cardiol       Date:  2018-03-10       Impact factor: 24.094

6.  Associations Between Marijuana Use and Cardiovascular Risk Factors and Outcomes: A Systematic Review.

Authors:  Divya Ravi; Mehrnaz Ghasemiesfe; Deborah Korenstein; Thomas Cascino; Salomeh Keyhani
Journal:  Ann Intern Med       Date:  2018-01-23       Impact factor: 25.391

7.  Medical Reasons for Marijuana Use, Forms of Use, and Patient Perception of Physician Attitudes Among the US Population.

Authors:  Patrick M Azcarate; Alysandra J Zhang; Salomeh Keyhani; Stacey Steigerwald; Julie H Ishida; Beth E Cohen
Journal:  J Gen Intern Med       Date:  2020-04-06       Impact factor: 5.128

Review 8.  What is the Current Knowledge About the Cardiovascular Risk for Users of Cannabis-Based Products? A Systematic Review.

Authors:  Emilie Jouanjus; Valentin Raymond; Maryse Lapeyre-Mestre; Valérie Wolff
Journal:  Curr Atheroscler Rep       Date:  2017-06       Impact factor: 5.113

Review 9.  Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.

Authors:  Pal Pacher; Sabine Steffens; György Haskó; Thomas H Schindler; George Kunos
Journal:  Nat Rev Cardiol       Date:  2017-09-14       Impact factor: 32.419

Review 10.  Neuropathology of substance use disorders.

Authors:  Jean Lud Cadet; Veronica Bisagno; Christopher Mark Milroy
Journal:  Acta Neuropathol       Date:  2013-11-29       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.